Navigation Links
Hoya Announces Third Quarter Financial Results
Date:2/9/2010

TOKYO, February 9 /PRNewswire-FirstCall/ -- Hoya Corporation today announced financial results for the third quarter ended December 31, 2009. Net sales were 106.8 billion yen for the quarter, a 5.2% decrease from 112.7 billion yen in the same period last year. Operating income was 18.9 billion yen, a 13.8% increase from 16.6 billion yen in the same period last year, mainly due to increase in orders and productivity. Compared to the second quarter ended September 30, 2009, sustained recovery in orders since April resulted in an increase of both net sales and operating income.

Net income for the third quarter was down 6.5% to 11.7 billion yen compared to the same period last year. Earnings per share for the quarter were 27.24 yen compared with 29.13 yen in the same period last year.

"In this anemic economy, the good news is that there is an increase in orders and the demand for larger memory capacity in glass memory disk business," said Hiroshi Suzuki, chief executive officer of HOYA. "The development of technology for 3D television also has a good impact on our LCD photo mask business."

For the first nine months ended December 31, 2009, net sales were 308.6 billion yen, down 16.9% compared to 371.2 billion yen in the same period previous year, operating income was 46.9 billion yen, down 20.6% compared to 59.1 billion yen in the same period previous year, and net income was '/>"/>

SOURCE Hoya Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Ranibizumab Market, ... by Novartis, ranibizumab was approved by CFDA to treat ... only Lucentis, a product of Novartis, is available in ... first self- developed drug for the treatment of wet ...
(Date:8/28/2015)... Denmark and ATLANTA , August ... the US Food and Drug Administration (FDA) cleared the MagVita ... in adult patients who have failed to receive satisfactory improvement ... a non-invasive technique for stimulating neural tissue in the part ... Disorder. The procedure has been proven safe and effective and ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... brings hope for the fight against prostate cancer. While the ... receive this unfortunate diagnosis in 2012, numbers also indicate that ... deaths dropped 39 percent since the 1990s. The widespread adaptation ... the form of robotic prostatectomy , is leading the ...
... patent cliffs and shrinking pipelines, the pharmaceutical industry is ... M&A activities - as a way to maintain growth ... one to effectively put into practice. The process of ... potential pitfalls. With 2012 shaping up to be a ...
Cached Medicine Technology:PSA Testing and Robotic Surgery Take on Prostate Cancer 2PSA Testing and Robotic Surgery Take on Prostate Cancer 3Excellence Services Program Delivers a Road Map to Successfully Guide the Pharmaceutical Industry Through the New Alliance Landscape 2
(Date:8/28/2015)... ... August 28, 2015 , ... ... management, Decatur County Memorial Hospital recently transitioned management companies to partner with Wound ... Management for their outpatient wound center. , Transitioning wound care management providers ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 ... Zoo to celebrate children helping children, a thank you to the many creative ... have contributed to the United Methodist initiative to end malaria deaths. , The ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... An ... journey that local pizza maker Paul LaRocco has gone through to open a pizzeria ... approval and permitting process tends to take several months, but the current process, having ...
(Date:8/28/2015)... , ... August 28, 2015 , ... For Dallas, the ... taking part with their subsidiary USPI Tenet Health. , The American Heart Association hosts ... disease and stroke. They believe that together, a difference can be made. Walkers can ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by Medical ... received FDA clearance for results that last for two years, the longest of any ... patients who are looking for a long-lasting, effective solution for their cellulite, according to ...
Breaking Medicine News(10 mins):Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... are resistant to androgen deprivation therapy are more invasive ... androgen dependent prostate cancers, UCLA cancer researchers have found. ... first, but they progress and become resistant over time. ... despite surgical or medical therapies that deplete testosterone. The ...
... of pure silica coated with an active material could ... other hazardous materials from water much more effectively and ... to researchers writing in the current issue of the ... Ping Chan of the Ian Wark Research Institute, at ...
... /PRNewswire-FirstCall/ - SXC Health Solutions, Inc.,("SXC" or the ... leading provider of,pharmacy benefits management services, announces that ... present at Raymond James, 29th,Annual Institutional Investors Conference ... SXC,s presentation will take place on Monday,March 3, ...
... work in humans , , WEDNESDAY, Feb. 20 (HealthDay News) -- ... Stanford University researchers report. , The use of neural cells ... the rats, physical abilities, according to the study, which is ... of Science ONE . The stroke damage induced by the ...
... HATBORO, Pa., Feb. 20 InfoLogix, Inc.,(Nasdaq: ... mobility,solutions for the healthcare and commercial industries, announced ... at the Growth & Value,Investor Conference to be ... on,February 27-28, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... to grow at a compound annual growth rate ... WALTHAM, Mass., Feb. 20 According to Millennium,Research Group,s Global ... report, the US hyaluronic acid,(HA) dermal filler market will grow ... through 2011., Growth in this market will be driven ...
Cached Medicine News:Health News:Hormone refractory prostate cancers more likely to spread to other organs 2Health News:Cleaner water through nanotechnology 2Health News:Stem Cells Repair Stroke Damage in Rats 2Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 2Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 3Health News:Hyaluronic Acid Dermal Filler Market Skyrockets 2
... 50/60 Hz, 100/120 V Fast - Powerful ... rotor spins up to 14,000 rpm (18,000 x g) ... Cell Virus Isolation Fits on crowded ... Comes complete with a 24-place aerosol-tight, autoclavable fixed-angle rotor ...
Inquire...
... designed to create the ideal environment for nucleic ... 99.9C) , Variable speed control (10 to ... it be for washing or hybridizing , ... inside the chamber, ,is situated above a touch ...
... HybriCycler Hybridization Oven with circular clear acrylic ... tubes. HC-3000 HybriCycler Oven features microprocessor operation ... feet balance the unit., Carousel rotates ... carousel is ,easily removable , Bottle ...
Medicine Products: